Home
News
Careers
Contact Us
About EA
EA Evolution
Team Profile
Vision & Values
Board of Directors
Fact sheet
Expertise
Biosimilars Development
Cell Therapy Expertise
Diagnostic Imaging Agent Development
Serving Generic Companies
Experience
Therapeutic Experience
Study Type
Region
Global Presence
Worldwide
Asia Pacific
Europe
America
Services
Bioavailability and Bioequivalence Services (PK/PD)
Clinical Trials Management
Clinical Data Management
Medical Services
Regulatory Affairs
Pharmacovigilance
Central Laboratory
Links
Whitepapers
Brochures
EA Celebrates 25 Years
Bioanalytical Method Library
Corporate Brochure
BABE Brochure
CDM Brochure
Clinical Reference Lab Brochure
Russia
WHO
Clinicaltrials.gov
EMA
MHW
KFDA
CTRI
SFDA
Russia
ANVISA
ACRO
CDISC
Eurotrial
Clinserv
EPS
CnR
LKF
FMD
Events
Testimonials
Whitepapers
Clinical development strategies
“A remarkable journey” Anders Malm, Managing Director Germany & Nordic Countries and CEO North America, talking about Ecron Acunova, Frankfurt 2014
“The role of medical teams in clinical development” by Dr. C. Drummer at CPhI, Frankfurt 2013
"What makes a country competitive for clinical research?" an article by D. A. Prasanna in Biospectrum
"Biosimilar Clinical Development - Opportunities and Challenges" by D.A. Prasanna presented at CPHI Frankfurt, October 2011
"Adaptive Clinical Trials: Are the Regulatory Regimes of India and the U.S. Ready?“
Panelist: D A Prasanna presented on June 28th 2011 at Patton Boggs (on the sidelines of BIO Washington), June 2011
“Frugal innovation in bringing new drugs to market” presented by Mr. D A Prasanna, Chairman of Ecron Acunova CRO delivered at Copenhagen on May 16th 2011 on the occasion of launch of Ecron Acunova A/S, May 2011
Geographical considerations in clinical development
"Clinical Trials in Europe: a 2011 Perspective“, Presented in Princeton at the ‘Meeting on Clinical trials in Europe’, September 2011
"Clinical Trials in Russia”, summary by EA, August 2011
Therapy area expertise
"Potential Value of Biosimilars", by Dr. Shabana Khan, at '3rd International's Conference on Biosimilars, OMICS Group, Hyderabad
"Biosimilar Strategy & 351K", by D. A. Prasanna, at 'CPhI 2014, Paris 2014
“Stemcell to Market faster”, by D. A. Prasanna, at ‘IsraStem 2013’, Tel Aviv 2013
“Cell Therapy Trials - How CROs can impact trial outcome” by Dr. S. Kher at Stemcell Symposium, Tel Aviv 2013
“Speed to Dermatology Market and Clinical Endpoint studies“ by D.A. Prasanna & Nurjehan Jivani at BA&BE; conference, Mumbai, December 2012
"World’s First Approved Stem Cell Drug“ – May 2012
"Stem cell therapy clinical development capabilities“ by D A Prasanna, London, March 2010
Clinical Research in Asia
Clinical Research in India – Stakeholder Roundtable anchored by Dr. Kher
"What should the New Indian Govt. do in Clinical Research" by D A Prasanna, Chairman ACRO India
BioSpectrum ranks EA No. 32 amongst top 50 biotech firms of India. No 7 amongst top 20 bioservices firms, 2010
“Offshore, Re-shore or Right-shore: A critical appraisal of risks and opportunities in the emerging markets with focus on India” by Dr. Antal K Hajos presented at 46th DIA Annual Meeting in Washington DC, June 2010
Why India’s regulatory environment supports the country as a favoured clinical trials destination and the associated advantages and challenges faced by sponsors in this market. By Dr. B G Jayasheel, Raj Pharma June 2010
“Potential of Clinical trials in India” by D A Prasanna presented at Bangalore India Bio, 4th June 2010
“Clinical Development Plan (CDP) – Claim and Feasibility” presented by PD Thomas Bethke, MD & Frank Rathgeb, MD and “Offshoring Using the Example of India – a Survey” presented by Antal K. Hajos, PhD at V. Interdisziplinäres Expertengespräch im PharmaProjekthaus. Reported by Eckhard Böttcher-Bühler at DGPharMed News 2010 | Jahrgang 12 | Heft 2 | Mai (Language: German), May 2010
Various
Optimal Central Image Evaluation by Dr. Kohkan Shamsi, Express Pharma May 2014
‘Open Innovation in Medical Devices’- address by D A Prasanna to 45 Medtech CEOs at BIO Korea May 2014
In-depth Understanding of SEA’s Regulatory Approval Process by Dr. Shabana Ayaaz at CPhI-South East Asia held at Jakarta on May 21 & 22 May 2014
“Recent trends in biosimilar development” by D A Prasanna at CPhI, Frankfurt 2013
”Factors driving Halal Pharma Market” by Dr. K. Shabana at CPhI, Kuala Lumpur 2013
Leave a message
Choose a file
Cancel
Whitepapers
Clinical development strategies
Geographical considerations in clinical development
Therapy area expertise
Clinical Research in Asia
Various
Submit your email address to start receiving newsletters from Ecron Acunova.
Cancel
Disclaimer
|
Privacy Policy
|
Site Map
